WE ARE DEDICATED TO CURING CANCER IN DOGS
We fund the most promising research projects to discover treatments to save lives of our beloved pets.
We seek therapies that are safe and can bring long-lasting regression to all types of cancer.
OUR DOGS DESERVE THE VERY BEST
We love our dogs as family members. But cancer strikes roughly 6 million dogs in the United States each year without discrimination: puppies and oldsters, mixed and pure-bred. Unlike human cancer research which is supported by massive fund-raising and government research dollars, canine cancer is studied only by a small number of researchers.
The Most Common
Cancers in Dogs
WE ARE TAKING ACTION
We actively seek out, engage and bring together teams of researchers, veterinary clinicians and biotech companies to create new treatments. Traditional therapies that rely only on chemotherapy or surgery are inadequate.
We especially emphasize cancer immunotherapy and combination therapies that can safely bring cures and long-lasting regression to cancer. We help ensure that promising pre-clinical research is followed up by clinical trials so that new treatments can be evaluated and ultimately made available to our pets, affordably, everywhere.
WE SEEK IMPACT
Dog cancers have strong similarities to human cancers including the way our immune systems fight cancer. That means we can apply knowledge and technologies being developed for tackling human cancers to helping dogs. We seek impact by taking these new treatments into clinical trials with canine patients.
If a new therapy proves to help dogs, it can also accelerate clinical studies for human patients.
There is a potential for a big win-win for both canine and human patients.